• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
HYD
Click for more information
0.00% 1.3¢

HYDRIX LIMITED - Charts / Financials

Market Cap $3.304M  ! watchlist Created with Sketch. Add to my watchlist
Technology Scientific & Technical Instruments

Hydrix Limited is an Australia-based specialist product designing, engineering and... Hydrix Limited is an Australia-based specialist product designing, engineering and medical device distribution company. The Company is engaged in the development of comprehensive products. Its segments include Hydrix Services, Hydrix Medical and Hydrix Ventures. Hydrix Services segment offers a comprehensive range of engineering, development and regulatory consulting services, including software, electronics, mechanical, industrial design and general product development services. Hydrix Medical distributes disruptive cardiovascular technologies that address unmet needs of patients and healthcare providers. Products include the Guardian real-time heart attack warning system from Avertix Medical, Implicity’s cloud-based artificial intelligence (AI)-driven remote cardiac patient monitoring and data management solution, and Echo IQ’s AI technology. Hydrix Services segment’s portfolio companies include Gyder Surgical Pty Ltd, Avertix Medical Inc., Memphasys Limited, and Cyban Pty Ltd.More

refresh Created with Sketch. REFRESH
Last update - 16.20pm 01/10/2024 (20 minute delay) ?
Day
Open 0.0¢   Day High 0.0¢   Day Low 0.0¢
Daily Volume 0
Bids   Sellers
Number Price Volume   Number Price Volume
1 1.2¢ 100000   1 1.3¢ 7466

Directors & Senior Management

Mr. Gavin Coote Executive Chairman of the Board
Ms. Alyn Tai Company Secretary
Ms. Julie King Non-Executive Director
Mr. Paul Lewis Non-Executive Director
Mr. Paul Martin Wright Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
1.3¢ 		Change
0.000(0.00%) 		Mkt cap ! $3.304M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 100000 1.2¢
 

Sellers (Offers)

Price($) Vol. No.
1.3¢ 7466 1
View Market Depth
Last trade - 16.12pm 01/10/2024 (20 minute delay) ?

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Iress runs 'hot' for Wealth Within's stock tips Financial services software play Iress (ASX:IRE) is the HotCopper Hot Stock tip this week from Wealth Within's chief analyst Dale Gillham and senior analyst Fil Tortevski.
Failure to report prompts ASX to impose multiple company suspensions The ASX today told more than 20 companies across many sectors that it would be imposing suspensions on them
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.